Literature DB >> 18180298

Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration.

Zhiping Li1, Chenguang Wang, Xuanmao Jiao, Sanjay Katiyar, Mathew C Casimiro, George C Prendergast, Michael J Powell, Richard G Pestell.   

Abstract

Cyclin D1 is an important cell cycle regulator, but in cancer its overexpression also increases cellular migration mediated by p27 KIP1 stabilization and RhoA inhibition. Recently, a common polymorphism at the exon 4-intron 4 boundary of the human cyclin D1 gene within a splice donor region was associated with an altered risk of developing cancer. Altered RNA splicing caused by this polymorphism gives rise to a variant cyclin D1 isoform termed cyclin D1b, which has the same N terminus as the canonical cyclin D1a isoform but a distinct C terminus. In this study we show that these different isoforms have unique properties with regard to the cellular migration function of cyclin D1. Although they displayed little difference in transcriptional co-repression assays on idealized reporter genes, microarray cDNA expression analysis revealed differential regulation of genes, including those that influence cellular migration. Additionally, whereas cyclin D1a stabilized p27 KIP1 and inhibited RhoA-induced ROCK kinase activity, promoting cellular migration, cyclin D1b failed to stabilize p27 KIP1 or inhibit ROCK kinase activity and had no effect on migration. Our findings argue that alternate splicing is an important determinant of the function of cyclin D1 in cellular migration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180298     DOI: 10.1074/jbc.M706992200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.

Authors:  Mathew C Casimiro; Marco Crosariol; Emanuele Loro; Adam Ertel; Zuoren Yu; William Dampier; Elizabeth A Saria; Alex Papanikolaou; Timothy J Stanek; Zhiping Li; Chenguang Wang; Paolo Fortina; Sankar Addya; Aydin Tozeren; Erik S Knudsen; Andrew Arnold; Richard G Pestell
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

Review 2.  New roles of cyclin D1.

Authors:  Richard G Pestell
Journal:  Am J Pathol       Date:  2013-07       Impact factor: 4.307

Review 3.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

Review 4.  Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b.

Authors:  Hui Meng; Lifeng Tian; Jie Zhou; Zhiping Li; Xuanmao Jiao; Wayne W Li; Markus Plomann; Zhishun Xu; Michael P Lisanti; Chenguang Wang; Richard G Pestell
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

6.  Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.

Authors:  Kongming Wu; Ke Chen; Chenguang Wang; Xuanmao Jiao; Liping Wang; Jie Zhou; Jing Wang; Zhiping Li; Sankar Addya; Poul H Sorensen; Michael P Lisanti; Andrew Quong; Adam Ertel; Richard G Pestell
Journal:  Cancer Res       Date:  2013-12-12       Impact factor: 12.701

7.  Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.

Authors:  Tapasree Roy Sarkar; Shikha Sharan; Jun Wang; Snehalata A Pawar; Carrie A Cantwell; Peter F Johnson; Deborah K Morrison; Ju-Ming Wang; Esta Sterneck
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

8.  Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.

Authors:  Federica Sotgia; Francesco Del Galdo; Mathew C Casimiro; Gloria Bonuccelli; Isabelle Mercier; Diana Whitaker-Menezes; Kristin M Daumer; Jie Zhou; Chenguang Wang; Sanjay Katiyar; Huan Xu; Emily Bosco; Andrew A Quong; Bruce Aronow; Agnieszka K Witkiewicz; Carlo Minetti; Philippe G Frank; Sergio A Jimenez; Erik S Knudsen; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

9.  Cyclin K and cyclin D1b are oncogenic in myeloma cells.

Authors:  Véronique Marsaud; Guergana Tchakarska; Geoffroy Andrieux; Jian-Miao Liu; Doulaye Dembele; Bernard Jost; Joanna Wdzieczak-Bakala; Jack-Michel Renoir; Brigitte Sola
Journal:  Mol Cancer       Date:  2010-05-10       Impact factor: 27.401

10.  Cyclin D1 determines estrogen signaling in the mammary gland in vivo.

Authors:  Mathew C Casimiro; Chenguang Wang; Zhiping Li; Gabriele Di Sante; Nicole E Willmart; Sankar Addya; Lei Chen; Yang Liu; Michael P Lisanti; Richard G Pestell
Journal:  Mol Endocrinol       Date:  2013-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.